Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark
· Delayed Price · Currency is DKK 4.370
-0.090 (-2.02%)
Aug 15, 2025, 3:59 PM CET
CPH:SMSMED Revenue
Scandinavian Medical Solutions had revenue of 122.75M DKK in the half year ending March 31, 2025, with 27.54% growth. This brings the company's revenue in the last twelve months to 246.87M, up 24.99% year-over-year. In the fiscal year ending September 30, 2024, Scandinavian Medical Solutions had annual revenue of 226.68M with 18.56% growth.
Revenue (ttm)
246.87M
Revenue Growth
+24.99%
P/S Ratio
0.49
Revenue / Employee
8.82M
Employees
26
Market Cap
120.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 226.68M | 35.49M | 18.56% |
| Sep 30, 2023 | 191.19M | 80.66M | 72.98% |
| Sep 30, 2022 | 110.53M | 38.89M | 54.29% |
| Sep 30, 2021 | 71.64M | 29.69M | 70.78% |
| Sep 30, 2020 | 41.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.79B |
| Genmab | 23.16B |
| Demant | 22.59B |
| ALK-Abelló | 5.71B |
| H. Lundbeck | 23.52B |
| Ambu A/S | 5.83B |
| Zealand Pharma | 9.11B |